Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Introduction: The availability of simple, tolerable, therapies for hepatitis C virus (HCV)
infection with responses> 95% is one of the greatest medical advances in decades, offering …

Background To achieve WHO targets for the elimination of hepatitis C virus (HCV) as a
public threat, an increased uptake of HCV treatment among people who inject drugs (PWID) …

Globally, some 71 million people are chronically infected with hepatitis C virus (HCV).
Marginalized populations, particularly people who inject drugs (PWID), have low testing …

Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of
active infection in a single visit. This study evaluated the sensitivity and specificity of the …

Background Population‐level monitoring of hepatitis C virus (HCV) infected people across
cascades of care identifies gaps in access and engagement in care and treatment. We …

Background Following advances in treatment for hepatitis C (HCV), optimizing linkage to
care and adherence to treatment of people who inject drugs became of pivotal importance …

Abstract Cascade-of-care (CoC) monitoring is an important component of the response to
the global hepatitis C virus (HCV) epidemic. CoC metrics can be used to communicate, in …

This is the 22nd annual review of health surveillance data for HIV, viral hepatitis and
sexually transmissible infections in Australia. It is a reference document for organisations …

Background Uptake of hepatitis C virus (HCV) testing remains inadequate globally.
Simplified point-of-care tests should enhance HCV diagnosis and elimination. We aimed to …